期刊文献+

左西孟旦对急性失代偿性心力衰竭患者心功能的影响 被引量:5

下载PDF
导出
摘要 目的观察左西孟旦治疗急性失代偿性心力衰竭的临床疗效及对心室功能的影响。方法选取我院住院的30例急性失代偿性心力衰竭患者,给予上述患者常规抗心力衰竭治疗,包括利尿剂、血管扩张药和血管紧张素转换酶抑制剂等,并在此基础上加用左西孟旦静脉滴注,并于治疗前及治疗后24 h观察患者的血清BNP水平、左右心室射血分数及心肌做功指数。结果经过左西孟旦治疗后,患者的血清BNP明显降低(P<0.05),且能够显著的影响患者的左心室功能(P<0.05)。结论左西孟旦治疗急性失代偿性心力衰竭能够明显改善心力衰竭症状及心功能,改善心室重构,降低病死率。
出处 《齐齐哈尔医学院学报》 2014年第23期3485-3486,共2页 Journal of Qiqihar Medical University
  • 相关文献

参考文献8

  • 1陈桂荣,谢世全,韩瑞鸿.钙增敏剂左西孟旦的研究新进展[J].辽宁中医药大学学报,2011,13(3):198-199. 被引量:27
  • 2Lehtonen L, Poder P. The utility of levosimendar in the treatment of heart failure[ J]. Ann Med ,2007,39( 1 ) :2-17.
  • 3郭攀,王平,孙漾丽,等.左西孟旦治疗急性心力衰竭62例疗效观察[J].中华全科医学,2013,11(5):680-681.
  • 4Garcia - Gonzalez MJ, Dominguez-Rodrigaez A. New pharmacologic options in the treatment of acute coronary syndromes and myocardial ischemia-reperfusion injury: potential role of levosimendan [ J ]. Minerxi Cardioangio1,2007,55 ( 5 ) :625-635.
  • 5Nanas JN, Papazoglou PP, Terrovitis JV, et al. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone [J]. Am J Cardiol,2004 ,94(10) :1329-1332.
  • 6Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controiled, double-blind study (RUSSLAN) [ J ]. Eur Heart J,2002,23 ( 18 ) : 1422-1432.
  • 7急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:836
  • 8Kasikcioglu HA, Uyarel H, Tartan Z, et al. Do calcium sensitizers affect right ventricular functions in patients with chronic heart failure? [ J]. International Journal of Cardiology,2007,118:246- 248.

二级参考文献49

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献862

同被引文献32

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部